Loading...
Loading...
Application UK00914977102 · Registered
| Application Number | UK00914977102 |
| Status | Registered |
| Owner | Equifax Inc |
| Filed | 2016-01-05 |
| Registered | 2016-05-04 |
| Renewal Due | 2036-01-05 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. NEURODECISION is currently a registered UK trademark, with renewal due on 2036-01-05. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Platform as a service (PAAS) featuring computer software platforms for use in connection with evaluating credit and other data as risk predictors, financial credit risk modelling and analytics, and credit score analysis; providing on-line non-downloadable software for use in connection with evaluating credit and other data as risk predictors, financial credit risk modelling and analytics, and credit score analysis.
'NEURODECISION' is a registered trademark on the UK IPO register, owned by Equifax Inc. The application (UK00914977102) was filed on 5 January 2016 and registered on 4 May 2016. The registration is set to expire on 5 January 2036.
This mark is recorded under Class 42 (scientific, IT & design services).
The trademark is represented by Greenwoods Legal Services Limited.
UK trademark UK00914977102 for the mark 'NEURODECISION' in Class 42 is recorded on the UK IPO register as owned by Equifax Inc. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00914977102 for the mark 'NEURODECISION' as registered.
UK trademark UK00914977102 for the mark 'NEURODECISION' is registered in Class 42 (scientific, IT & design services). The filed specification reads: Class 42: Platform as a service (PAAS) featuring computer software platforms for use in connection with evaluating credit and other data as risk predictors, financial credit risk modelling and analytics, and credit score analysis; providing on-line non-downloadable software for use in connection with evaluating cred…
UK trademark UK00914977102 for the mark 'NEURODECISION' was filed at the UK IPO on 5 January 2016 and registered on 4 May 2016.
UK trademark UK00914977102 for the mark 'NEURODECISION' is currently recorded as valid until 5 January 2036, at which point it will need to be renewed with the UK IPO to remain in force.
Greenwoods Legal Services Limited is listed as the attorney / representative of record for UK trademark UK00914977102 for the mark 'NEURODECISION' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "NEURODECISION" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| NEURODECISIONSame applicant | 86684017 | 702 | 2015-07-06 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.